(Q42685186)

4 November 2017

title

Treatment of cytomegalovirus pneumonitis after bone marrow transplantation with 9-[2-hydroxy-1-(hydroxymethyl) ethoxymethyl] guanine (English)

1 reference

4 November 2017

P Selby

1

1 reference

4 November 2017

R L Powles

2

1 reference

4 November 2017

B Jameson

3

1 reference

4 November 2017

K Stolle

4

1 reference

4 November 2017

Y Tryhorn

5

1 reference

4 November 2017

H Stern

6

1 reference

4 November 2017

language of work or name

English

0 references

publication date

1 June 1986

1 reference

4 November 2017

1 reference

4 November 2017

volume

1

1 reference

4 November 2017

issue

8494

1 reference

4 November 2017

page(s)

1377-1378

1 reference

Interstitial pneumonitis after bone marrow transplantation. Assessment of risk factors

4 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2886%2991682-X

7 January 2021

9-([2-hydroxy-1-(hydroxymethyl)ethoxy]methyl)guanine: a selective inhibitor of herpes group virus replication

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2886%2991682-X

7 January 2021

Effect of 9-(1,3-dihydroxy-2-propoxymethyl)guanine on human cytomegalovirus replication in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2886%2991682-X

7 January 2021

9-(1,3-Dihydroxy-2-propoxymethyl)guanine for cytomegalovirus infections in patients with the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2886%2991682-X

7 January 2021

Activity of 9-[2-hydroxy-1-(hydroxymethyl)ethoxymethyl]guanine in the treatment of cytomegalovirus pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2886%2991682-X

7 January 2021

10.1016/S0140-6736(86)91682-X

Identifiers

DOI

1 reference

4 November 2017

1 reference